Status:
RECRUITING
Impact of NAFLD vs MAFLD Stigma on Quality of Life in Egyptian Patients
Lead Sponsor:
Tanta University
Conditions:
NAFLD
Eligibility:
All Genders
18+ years
Brief Summary
Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of liver disease worldwide. The global burden of NAFLD is about 30% of the population, With a higher prevalence in Egypt about 47...
Detailed Description
This cross-sectional study will be carried out in collaboration between the Tropical Medicine Department and Public Health Department, Tanta University Hospitals. A questionnaire in both digital and w...
Eligibility Criteria
Inclusion
- Patients ≥ 18 years old diagnosed with NAFLD/ NASH and willing to complete the survey.
- Physicians treating patients with NAFLD/NASH (hepatologists, gastroenterologists, endocrinologists, and internal medicine physicians).
Exclusion
- Unwilling to participate
Key Trial Info
Start Date :
May 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 15 2024
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT06503068
Start Date
May 1 2024
End Date
December 15 2024
Last Update
August 16 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tropical medicine department, Tanta University Hospitals
Tanta, Gharbyea, Egypt, 31527